One Gustave Levy Place 1136

New York City, NY, United States

One Gustave Levy Place 1136

New York City, NY, United States

Time filter

Source Type

Frontera J.A.,Mount Sinai School of Medicine | Gowda A.,Mount Sinai School of Medicine | Grilo C.,Mount Sinai School of Medicine | Gordon E.,One Gustave Levy Place 1136 | And 4 more authors.
Acta Neurochirurgica, Supplementum | Year: 2011

Objectives: The frequency and predictors of recurrent symptomatic and angiographic vasospasm after angioplasty or intra-arterial chemical vasodilatation (IACV) in patients with subarachnoid hemorrhage (SAH) are not well characterized. Methods: A retrospective review of serial clinical and angiographic data was conducted between 7/2001-6/2008 on spontaneous SAH patients who underwent endovascular therapy for symptomatic vasospasm. Results: Of 318 SAH patients, symptomatic vasospasm occurred in 80 (25%) and endovascular intervention was performed on 69 (22%) patients. Of these 69 patients, all received IACV in 274 vessels and 33 also underwent angioplasty in a total of 76 vessels. Recurrent angiographic vasospasm occurred in the same vessel segment in 9/23 (39%) patients who received both angioplasty + IACV compared to 40/49 (82%) of patients who received IACV alone (P < 0.001). Recurrent symptomatic vasospasm occurred in 10/26 (38%) angioplasty + IACV patients compared to 28/37 (76%) patients who received IACV alone (P = 0.003). The modified-Fisher Score, A1 spasm, distal and multi-vessel vasospasm predicted recurrent angiographic spasm after IACV alone (P < 0.05). Procedural complications occurred in 4% of IACV alone patients and 6% of angioplasty + IACV patients (P = 0.599). Conclusions: Recurrent angiographic or symptomatic vasospasm is not uncommon after angioplasty + IACV, but appears to occur significantly less than after IACV alone, without any increase in procedural complications. © Springer-Verlag/Wien 2011.

Loading One Gustave Levy Place 1136 collaborators
Loading One Gustave Levy Place 1136 collaborators